Terms: = Endocrine gland cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
4552 results:
1. Epidemiological profile of neuroendocrine tumors in adults in Brazil.
Brunelli Pujatti P; Paim V; Gonçalves R; Vilhena B; Bergmann A; Santos Thuler LC; Bulzico D
Arch Endocrinol Metab; 2024 May; 68():e230013. PubMed ID: 38709149
[TBL] [Abstract] [Full Text] [Related]
2. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
J D
Cesk Patol; 2024; 60(1):59-63. PubMed ID: 38697828
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.
Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J
J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382
[TBL] [Abstract] [Full Text] [Related]
4. A comparison of swallowing related quality of life in patients undergoing transoral endoscopic versus open thyroid surgery.
Deshmukh P; Shiva B; Yadav SK; Agarwal P; Sharma D; Johri G
World J Surg; 2024 Feb; 48(2):379-385. PubMed ID: 38686757
[TBL] [Abstract] [Full Text] [Related]
5. A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer.
Zhan F; Guo Y; He L
J Ovarian Res; 2024 Apr; 17(1):92. PubMed ID: 38685095
[TBL] [Abstract] [Full Text] [Related]
6. Naive and regulatory B-cell transcription patterns guide the increased risk of papillary thyroid carcinoma in obesity.
Yu Z; Xu Z; Li S; Tian Z; Yuan J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):118-126. PubMed ID: 38678617
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
[TBL] [Abstract] [Full Text] [Related]
8. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
9. Ultrasound-based deep learning radiomics model for differentiating benign, borderline, and malignant ovarian tumours: a multi-class classification exploratory study.
Du Y; Guo W; Xiao Y; Chen H; Yao J; Wu J
BMC Med Imaging; 2024 Apr; 24(1):89. PubMed ID: 38622546
[TBL] [Abstract] [Full Text] [Related]
10. Unlocking the Role of Age-Related Changes to Fibroblasts in Pancreatic cancer.
Isaacson A; Barki D; Scherz-Shouval R
Cancer Res; 2024 Apr; 84(8):1185-1187. PubMed ID: 38616657
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive analysis of the interaction of antigen presentation during anti-tumour immunity and establishment of AIDPS systems in ovarian cancer.
Sun W; Xu P; Gao K; Lian W; Sun X
J Cell Mol Med; 2024 Apr; 28(8):e18309. PubMed ID: 38613345
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
Li L; Hu Y; Li X; Ju B
Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
[TBL] [Abstract] [Full Text] [Related]
13. Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Bhaskari J; Bhagat R; Shilpa V; Premalata CS; Krishnamoorthy L
J Ovarian Res; 2024 Apr; 17(1):77. PubMed ID: 38594780
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of an ultrasound-based deep learning radiomics nomogram for predicting the malignant risk of ovarian tumours.
Du Y; Xiao Y; Guo W; Yao J; Lan T; Li S; Wen H; Zhu W; He G; Zheng H; Chen H
Biomed Eng Online; 2024 Apr; 23(1):41. PubMed ID: 38594729
[TBL] [Abstract] [Full Text] [Related]
15. Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid cancer: A Retrospective Study on a Korean Population.
Baek HS; Ha J; Kim K; Bae JS; Kim JS; Kim S; Lim DJ; Kim CM
Endocrinol Metab (Seoul); 2024 Apr; 39(2):310-323. PubMed ID: 38590123
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
17. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
Wang Y; Kong Y; Yang Q; Zhong C; Zhou D
Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008
[TBL] [Abstract] [Full Text] [Related]
18. Development and validation of a nomogram model for predicting distant metastasis of aged ≥50 patients with thyroid carcinoma: a SEER database analysis.
Yu JW; Pang R; Liu B; Zhang L; Kong LY
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2351-2362. PubMed ID: 38567598
[TBL] [Abstract] [Full Text] [Related]
19. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
Martínez-Moral MP; Tena MT; Martín-Carnicero A; Martínez A
Clin Chim Acta; 2024 Apr; 557():117895. PubMed ID: 38561063
[TBL] [Abstract] [Full Text] [Related]
20. The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.
Lu W; Wu G; Miao X; Ma J; Wang Y; Xu H; Shentu D; Xue S; Xia Q; Wang Y; Wang L
Cancer Immunol Immunother; 2024 Mar; 73(5):87. PubMed ID: 38554161
[TBL] [Abstract] [Full Text] [Related]
[Next]
